What’s New

Latest News

News
Rheumatoid Arthritis Mortality Declines Among US Postmenopausal Women
02/11/2026
Grace Taylor, MS, MA
Rheumatoid arthritis (RA) mortality among US postmenopausal women has declined by more than half since 1999, but persistent racial, regional, and age-based disparities—and a pandemic-related spike—highlight ongoing inequities in outcomes.
Rheumatoid arthritis (RA) mortality among US postmenopausal women has declined by more than half since 1999, but persistent racial, regional, and age-based disparities—and a pandemic-related spike—highlight ongoing inequities in outcomes.
Rheumatoid arthritis (RA)...
02/11/2026
First Report Managed Care
First Report Managed Care
News
Lifetime Alcohol Intake Linked to Colorectal Cancer Risk
02/11/2026
Jessica Garlewicz
For gastroenterologists, the key takeaway is that cumulative alcohol exposure and long-term drinking patterns matter when assessing CRC risk.
For gastroenterologists, the key takeaway is that cumulative alcohol exposure and long-term drinking patterns matter when assessing CRC risk.
For gastroenterologists, the key...
02/11/2026
Gastroenterology
Gastroenterology
AI + ECG
Study Shows AccurKardia’s AI-Enabled ECG Can Detect Aortic Stenosis Years Before Valve Replacement and Improve Mortality Risk Prediction
02/11/2026
The study found that AK-AVS can detect aortic stenosis through routine ECGs up to 4.5 years before TAVR intervention, potentially enabling earlier detection, easier-to-access monitoring, and better timing of intervention.
The study found that AK-AVS can detect aortic stenosis through routine ECGs up to 4.5 years before TAVR intervention, potentially enabling earlier detection, easier-to-access monitoring, and better timing of intervention.
The study found that AK-AVS can...
02/11/2026
Cath Lab Digest
Cath Lab Digest
News
Patient Navigation Improves Colorectal Cancer Screening in Washington, DC Safety Net
02/11/2026
Hannah Musick
A evaluation at a Washington, DC safety net health system found that patient navigation improved colorectal cancer screening and follow-up completion at a moderate per-patient cost.
A evaluation at a Washington, DC safety net health system found that patient navigation improved colorectal cancer screening and follow-up completion at a moderate per-patient cost.
A evaluation at a Washington, DC...
02/11/2026
Journal of Clinical Pathways
Journal of Clinical Pathways
FDA Approval
FDA Approves Pembrolizumab-Based Regimens for Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
02/10/2026
Emily Estrada
On February 10, 2026, the FDA approved pembrolizumab and pembrolizumab and berahyaluronidase alfa-pmph in combination with paclitaxel, with or without bevacizumab, for patients with PD-L1-positive, platinum-resistant epithelial ovarian,...
On February 10, 2026, the FDA approved pembrolizumab and pembrolizumab and berahyaluronidase alfa-pmph in combination with paclitaxel, with or without bevacizumab, for patients with PD-L1-positive, platinum-resistant epithelial ovarian,...
On February 10, 2026, the FDA...
02/10/2026
Oncology
Oncology
Research Highlights
Pulmonary Rehabilitation May Improve 5-Year Survival in Interstitial Lung Disease
02/10/2026
Rebecca Mashaw
The absence of a survival difference at 10 years highlights the progressive nature of ILD and underscores the need for ongoing disease-modifying therapies alongside supportive interventions like pulmonary rehabilitation.
The absence of a survival difference at 10 years highlights the progressive nature of ILD and underscores the need for ongoing disease-modifying therapies alongside supportive interventions like pulmonary rehabilitation.
The absence of a survival...
02/10/2026
Rheumatology & Arthritis
Rheumatology & Arthritis
PharmLaw
Novo Nordisk Sues Hims & Hers as FDA Moves to Restrict Compounded GLP-1 Drugs
02/10/2026
Juliet Gallagher
Novo Nordisk has escalated its fight against compounded semaglutide products by filing a patent infringement lawsuit against Hims & Hers Health, while the US Food and Drug Administration (FDA) announced sweeping enforcement actions aimed at...
Novo Nordisk has escalated its fight against compounded semaglutide products by filing a patent infringement lawsuit against Hims & Hers Health, while the US Food and Drug Administration (FDA) announced sweeping enforcement actions aimed at...
Novo Nordisk has escalated its...
02/10/2026
Pharmacy Learning Network
Pharmacy Learning Network

Latest Research

Cover Story Jan/Feb
The Dermatologist
Forward Focus: Top Trends in Dermatology for 2026
Vol. 34, Issue 1, Issue February 2026
CLD 2026 Jan Feb cover..png
Cath Lab Digest
Impact of TAVR on Functional vs. Degenerative Mitral Regurgitation
Vol. 34, Issue 1, Issue February 2026

HMP Global Learning Network

Featured Interviews

Gustavo Oderich, MD, Robert Rhee, MD, and Sukgu Han, MD
sponsored video
Gustavo Oderich, MD, Robert Rhee, MD, and Sukgu Han, MD Discuss Evolving Treatment Algorithms in AAA Repair of Short, Angulated Necks
02/01/2026
Gustavo S. Oderich, MD; Robert Rhee, MD; Sukgu Han, MD
Three experts share their perspective on the GORE EXCLUDER Conformable AAA Endoprosthesis.
Three experts share their perspective on the GORE EXCLUDER Conformable AAA Endoprosthesis.
Three experts share their...
02/01/2026
Vascular Disease Management
tourniquet stop the bleed DeBoer
Videos
Pediatric Video Tutorial: Stop the Bleed Part 2—Tourniquet Tips
01/30/2026
Scott DeBoer, RN, MSN, CPEN, CEN, CCRN, CFRN
When it comes to tourniquets, whether for little ones or big people, practice and proper placement can be lifesavers.
When it comes to tourniquets, whether for little ones or big people, practice and proper placement can be lifesavers.
When it comes to tourniquets,...
01/30/2026
EMSWorld
Sri Kota, MSN, BA, APN, AGNP-C, AOCNP
Conference Coverage
Clinical Strategies for the Assessment and Management of Antibody-Drug Conjugate Toxicities
01/30/2026
Sri Kota, MSN, BA, APN, AGNP-C, AOCNP
Sri Kota, MSN, BA, APN, AGNP-C, AOCNP, reviewed the mechanisms, expanding clinical use, and payload-driven toxicities of antibody-drug conjugates, emphasizing practical strategies for toxicity recognition, management, and optimizing patient...
Sri Kota, MSN, BA, APN, AGNP-C, AOCNP, reviewed the mechanisms, expanding clinical use, and payload-driven toxicities of antibody-drug conjugates, emphasizing practical strategies for toxicity recognition, management, and optimizing patient...
Sri Kota, MSN, BA, APN, AGNP-C,...
01/30/2026
Oncology Learning Network APP Institute
CTP News Desk hero image
Viewpoints
Avoiding Audits and Making Sure You Get Paid
01/30/2026
Caroline E. Fife, MD, FAAFP, CWS, FUHM
Noting an increase in audits, Dr. Fife advises clinicians on a prudent product selection process and how to avoid being audited.
Noting an increase in audits, Dr. Fife advises clinicians on a prudent product selection process and how to avoid being audited.
Noting an increase in audits,...
01/30/2026
Wounds
Alison Schram, MD, Memorial Sloan Kettering Cancer Center
Videos
Treating NRG1 Fusion-Positive Non-Small Cell Lung Cancer
01/02/2026
Alison Schram, MD
Alison Schram, MD, discusses the treatment course taken for a case of a patient with non-small cell lung cancer with a CD74-NRG1 gene fusion.
Alison Schram, MD, discusses the treatment course taken for a case of a patient with non-small cell lung cancer with a CD74-NRG1 gene fusion.
Alison Schram, MD, discusses the...
01/02/2026
Oncology
Matthew Regulski, DPM, FFPM, RCPS (Glasgow), DABMSP
Viewpoints
Cutting Costs, Raising Standards: The Case for Evidence-Based CTP Use
12/30/2025
Matthew J. Regulski, DPM, ABMSP, CMET, FAPWH(c)
CMS reimbursement reforms are reshaping the use of skin substitutes in wound care, phasing out high-cost, low-evidence products in favor of therapies backed by rigorous clinical data. New models like WISeR promote prior authorization to...
CMS reimbursement reforms are reshaping the use of skin substitutes in wound care, phasing out high-cost, low-evidence products in favor of therapies backed by rigorous clinical data. New models like WISeR promote prior authorization to...
CMS reimbursement reforms are...
12/30/2025
Wounds
Michael Kappelman
From the AIBD Open Air Studio
The Sherman Prize: Michael Kappelman, MD
12/29/2025
Michael Kappelman, MD
Dr Michael Kappelman, one of the Sherman Prize winners for 2025, speaks from the Open Air Studio at the Advances in IBD meeting about his clinical and research work with pediatric patients with ulcerative colitis or Crohn's disease.
Dr Michael Kappelman, one of the Sherman Prize winners for 2025, speaks from the Open Air Studio at the Advances in IBD meeting about his clinical and research work with pediatric patients with ulcerative colitis or Crohn's disease.
Dr Michael Kappelman, one of the...
12/29/2025
Advances in Inflammatory Bowel Disease Network
CTP News Desk Image
Viewpoints
Observations on Potential Pivots and Continued Change
12/01/2025
Scott Nelson
This speaker expounds on potential trends he sees for CTPs in 2026.
This speaker expounds on potential trends he sees for CTPs in 2026.
This speaker expounds on...
12/01/2025
Wounds
Corey Siegel
Conference Coverage
Corey Siegel, MD, on Improving IBD Care Models
11/28/2025
Corey A. Siegel, MD, MS
In the J Edward Burke Distinguished Lecture at the ACG Scientific Meeting, Dr Corey Siegel outlined 5 problems in advancing the care of patients with inflammatory bowel disease, and discussed how the RADIUS program begun at his institution...
In the J Edward Burke Distinguished Lecture at the ACG Scientific Meeting, Dr Corey Siegel outlined 5 problems in advancing the care of patients with inflammatory bowel disease, and discussed how the RADIUS program begun at his institution...
In the J Edward Burke...
11/28/2025
Advances in Inflammatory Bowel Disease Network
BDHC thumbnail
Videos
Breaking Down Cancer Prevention: What Really Works?
11/26/2025
John Hennessy, MBA; Michael Kolodziej, MD
In this episode of Breaking Down Health Care, John Hennessy and Dr. Michael Kolodziej explore the crucial difference between cancer screening and true cancer prevention, highlighting how lifestyle changes, vaccines, and emerging therapies...
In this episode of Breaking Down Health Care, John Hennessy and Dr. Michael Kolodziej explore the crucial difference between cancer screening and true cancer prevention, highlighting how lifestyle changes, vaccines, and emerging therapies...
In this episode of Breaking Down...
11/26/2025
Cancer Care Business Exchange

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use